These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 30957954)
81. AZD5213: a novel histamine H3 receptor antagonist permitting high daytime and low nocturnal H3 receptor occupancy, a PET study in human subjects. Jucaite A; Takano A; Boström E; Jostell KG; Stenkrona P; Halldin C; Segerdahl M; Nyberg S Int J Neuropsychopharmacol; 2013 Jul; 16(6):1231-9. PubMed ID: 23217964 [TBL] [Abstract][Full Text] [Related]
82. Discovery of Potential, Dual-Active Histamine H Kuder KJ; Kotańska M; Szczepańska K; Mika K; Reiner-Link D; Stark H; Kieć-Kononowicz K Molecules; 2021 Apr; 26(8):. PubMed ID: 33921144 [TBL] [Abstract][Full Text] [Related]
94. A Photoswitchable Agonist for the Histamine H Hauwert NJ; Mocking TAM; Da Costa Pereira D; Lion K; Huppelschoten Y; Vischer HF; De Esch IJP; Wijtmans M; Leurs R Angew Chem Int Ed Engl; 2019 Mar; 58(14):4531-4535. PubMed ID: 30735597 [TBL] [Abstract][Full Text] [Related]
95. Discovery and Preclinical Validation of [(11)C]AZ13153556, a Novel Probe for the Histamine Type 3 Receptor. Schou M; Varnäs K; Jureus A; Ahlgren C; Malmquist J; Häggkvist J; Tari L; Wesolowski SS; Throner SR; Brown DG; Nilsson M; Johnström P; Finnema SJ; Nakao R; Amini N; Takano A; Farde L ACS Chem Neurosci; 2016 Feb; 7(2):177-84. PubMed ID: 26529287 [TBL] [Abstract][Full Text] [Related]
96. A qualitative model for the histamine H3 receptor explaining agonistic and antagonistic activity simultaneously. de Esch IJ; Timmerman H; Menge WM; Nederkoorn PH Arch Pharm (Weinheim); 2000 Aug; 333(8):254-60. PubMed ID: 11008375 [TBL] [Abstract][Full Text] [Related]
97. The naturally occurring mutation Y197C does not affect the expression or signaling of the human histamine H Flores-Clemente C; Escamilla-Sánchez J; Arias JM; Arias-Montaño JA Neurosci Lett; 2017 Feb; 641():77-80. PubMed ID: 28126588 [TBL] [Abstract][Full Text] [Related]
98. Constitutive activity of the histamine H3 receptor. Arrang JM; Morisset S; Gbahou F Trends Pharmacol Sci; 2007 Jul; 28(7):350-7. PubMed ID: 17573125 [TBL] [Abstract][Full Text] [Related]
99. JNJ10181457, a histamine H3 receptor inverse agonist, regulates in vivo microglial functions and improves depression-like behaviours in mice. Iida T; Yoshikawa T; Kárpáti A; Matsuzawa T; Kitano H; Mogi A; Harada R; Naganuma F; Nakamura T; Yanai K Biochem Biophys Res Commun; 2017 Jul; 488(3):534-540. PubMed ID: 28526411 [TBL] [Abstract][Full Text] [Related]
100. [The histamine H3 receptor: a new target for the treatment of arousal and cognitive disorders]. Arrang JM Ann Pharm Fr; 2007 Jul; 65(4):275-84. PubMed ID: 17652997 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]